1. Home
  2. TSAT vs IRWD Comparison

TSAT vs IRWD Comparison

Compare TSAT & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Telesat Corporation

TSAT

Telesat Corporation

HOLD

Current Price

$40.30

Market Cap

697.5M

Sector

Industrials

ML Signal

HOLD

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$3.64

Market Cap

687.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSAT
IRWD
Founded
1969
1998
Country
Canada
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
697.5M
687.4M
IPO Year
2021
2009

Fundamental Metrics

Financial Performance
Metric
TSAT
IRWD
Price
$40.30
$3.64
Analyst Decision
Buy
Buy
Analyst Count
5
4
Target Price
★ $65.70
$6.10
AVG Volume (30 Days)
98.6K
★ 1.7M
Earning Date
11-03-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 1400.00
EPS
N/A
★ 0.55
Revenue
N/A
★ $298,276,000.00
Revenue This Year
N/A
$59.19
Revenue Next Year
N/A
$4.80
P/E Ratio
★ N/A
$6.43
Revenue Growth
N/A
★ 8.88
52 Week Low
$23.01
$1.47
52 Week High
$61.54
$5.78

Technical Indicators

Market Signals
Indicator
TSAT
IRWD
Relative Strength Index (RSI) 48.53 38.25
Support Level $44.96 $3.04
Resistance Level $46.56 $3.96
Average True Range (ATR) 2.10 0.18
MACD -0.14 -0.03
Stochastic Oscillator 47.98 6.62

Price Performance

Historical Comparison
TSAT
IRWD

About TSAT Telesat Corporation

Telesat Corp is a satellite operator, that provides its customers with mission-critical communications services. It operates in a single operating segment, in which it provides satellite-based services to its broadcast, enterprise, and consulting customers around the world. The company has two operating segments: GEO services (GEO) segment that refers to the operation of the fleet of GEO satellite and LEO services (LEO) segment that refers to the deployment and operation of the Telesat Lightspeed constellation Geographically, it derives a majority of its revenue from Canada. It derives revenue from Broadcast, Enterprise, Consulting, and others.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.

Share on Social Networks: